Based on EPIC algorithm, the low-risk subgroup had a higher proportion of B cells, CD4+ T cells, and CD8+ T cells, while cancer-associated fibroblasts (CAFs) were shown to be significantly greater in high-risk patients (Figure 6B). The gene discussed is CD4; the disease is cancer.